FRAGILE X SYNDROME
Clinical trials for FRAGILE X SYNDROME explained in plain language.
Never miss a new study
Get alerted when new FRAGILE X SYNDROME trials appear
Sign up with your email to follow new studies for FRAGILE X SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Brain wave study tests drugs for genetic disorder
Disease control OngoingThis study is testing single doses of three existing medications—baclofen, roflumilast, and memantine—to see if they can improve brain activity and behavior in adults with Fragile X Syndrome. Researchers will measure changes in brain waves and ask caregivers about symptoms after …
Matched conditions: FRAGILE X SYNDROME
Phase: PHASE2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Four-Year safety check for promising fragile x drug begins
Disease control OngoingThis is a four-year follow-up study for adolescent and adult males with Fragile X Syndrome who have already taken the investigational drug BPN14770 in earlier trials. The main goal is to check the long-term safety and side effects of the drug. Researchers will also track changes …
Matched conditions: FRAGILE X SYNDROME
Phase: PHASE3 • Sponsor: Tetra Discovery Partners • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Skin gel offers hope for managing fragile x symptoms in kids
Symptom relief ENROLLING_BY_INVITATIONThis study is testing the long-term safety and effects of a CBD gel applied to the skin for children and young adults with Fragile X Syndrome. It is an extension study for up to 550 participants, aged 3 to 18, who were in previous related trials. Parents or caregivers apply the g…
Matched conditions: FRAGILE X SYNDROME
Phase: PHASE2, PHASE3 • Sponsor: Zynerba Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Feb 24, 2026 14:05 UTC
-
Scientists test if common ADHD drug can boost brainpower in kids with disabilities
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to see if a standard extended-release ADHD medication (methylphenidate) can improve specific thinking skills like attention and memory in children and teens who have both an intellectual disability and ADHD. Researchers will measure changes using a set of computer…
Matched conditions: FRAGILE X SYNDROME
Phase: PHASE1 • Sponsor: University of California, Davis • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC